Biobetters: IFN-α2b Variants with Reduced Immunogenicity for the Treatment of Human Viral Diseases
For more than three decades, IFN-α2b has been widely used for the treatment of multiple human viral infections such as chronic hepatitis B and C, and certain types of cancers. However, IFN-α2b can be immunogenic, and these undesired immune responses can lead to a decrease in therapeutic efficacy. In...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2023
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/87341 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Biobetters: IFN-α2b Variants with Reduced Immunogenicity for the Treatment of Human Viral Diseases
- Immunogenicity Study of Biosimilar Candidates
- Ferret TNF-α and IFN-γ Immunoassays
- The Role of Type I IFN and TNF-α in the Pathogenesis of Sarcoidosis
- An overview of the herbal treatment of viral diseases /
- HIV-1 Glycoprotein Immunogenicity
- Influence of the Interferon–Gamma (IFN–γ) and Tumor Necrosis Factor Alpha (TNF–α) Gene Polymorphisms in TB Occurrence and Clinical Spectrum